Discover the Latest Updates from Century Therapeutics: Preclinical Data Presented at SITC 37th Annual Meeting
Century Therapeutics Announces Exciting Developments in Cellular Therapy During the recent SITC 37th Annual Meeting, Century Therapeutics presented groundbreaking preclinical data that supports their next generation platform for iPSC-derived NK cells. These cells have been engineered with multiple gene edits to improve their persistence and anti-tumor efficacy. This is a significant advancement in the field…